Congestive Heart Failure: World’s First Endovascular Neuromodulation Device (Enopace, Israel) Implanted in Man
Enopace Biomedical, an israeli developer based in Caesare of minimally invasive, implantable endovascular neuromodulation therapy for heart failure patients, announced today the first successful human implantation of its Harmony™ System, a catheter-based neurostimulator device to treat patients with congestive heart failure. The procedure…